CAS: 66-97-7; 7H-Furo[3,2-G]Chromen-7-One

该化合物是合成的呋喃复合物,用作皮肤病(如psorlipic和vipligo)等皮肤病光疗处理的光化敏化剂,其主要优势在于它能够有选择地吸收紫外线-A辐射,对皮肤产生有益影响,同时尽量减少副作用,从而提供有效的治疗选择,并带来受控治疗结果.

结构式图片

相似化合物

2009-24-7 484-20-8 298-81-7

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号849144-95-2 xanthoarnol | CAS号6544-89-4 3,4-dihydropsoralen | CAS号7535-48-0 4',5'-dihydrops... | CAS号16851-02-8 2-(2-ox°Chromen... | CAS号52656-95-8 7-oxo-2,3-dihyd... | CAS号15085-71-9 小芸木素 | CAS号287171-02-2 (+)-(2'S,3'R)-3... | CAS号13196-11-7 6-苯并呋喃酚 | CAS号623-47-2 丙炔酸乙酯 | CAS号20073-22-7 5-Benzofurancar... | CAS号6544-89-4 3,4-dihydropsoralen | CAS号7535-48-0 4',5'-dihydrops... | CAS号19881-52-8 tetrahydropsoralen

合成工艺路线路线简述

  • 合成目标产物 Psoralen 主要起始原料 7H-Furo[3,2-G][1]Benzopyran-7-One, 2,3-Dihydro-3-Hydroxy-2-(1-Hydroxy-1-Methylethyl)-, (2S,3R)-
  • (文献来源)合成步骤主要原料 7H-Furo[3,2-G][1]Benzopyran-7-One, 2,3-Dihydro-3-Hydroxy-2-(1-Hydroxy-1-Methylethyl)-, (2S,3R)-
(2'S,3'R)-3'-Hydroxymarmesin置于三氟乙酸体系中,用 二氯甲烷 作为反应溶剂,化学反应 1.33H,以100%的收率获得产物补骨脂素
参考文献:Synthesis Of 2,3-Dihydro-3-Hydroxy-2-Hydroxylalkylbenzofurans From Epoxy Aldehydes. One-Step Syntheses Of Brosimacutin G,Vaginidiol,Vaginol,Smyrindiol,Xanthoarnol,And Avicenol A. Biomimetic Syntheses Of Angelicin And Psoralen
标题:Synthesis Of 2,3-Dihydro-3-Hydroxy-2-Hydroxylalkylbenzofurans From Epoxy Aldehydes. One-Step Syntheses Of Brosimacutin G,Vaginidiol,Vaginol,Smyrindiol,Xanthoarnol,And Avicenol A. Biomimetic Syntheses Of Angelicin And Psoralen
摘要:[graphics]We Have Developed Two Practical One-Step Syntheses Of 2,3-Dihydro-3-Hydroxy-2-Hydroxyalkylbenzofurans From Readily Available Optically Pure Alpha,Beta-Epoxy Aldehydes. Electron-Deficient Resorcinols React With Epoxy Aldehydes Using Either Cs2Co3 In Dmf Or Koh/cacl2 In Meoh To Give Adducts 13,16,18,20,21,And Brosimacutin G (6T). Grignard Reagents Prepared By Low-Temperature Halogen-Metal Exchange Of Acetoxy Iodocoumarins 35D And 40 And Acetoxy Bromonaphthalene 41 Add To Epoxy Aldehyde (S)-26 To Complete The First Syntheses Of Vaginidiol (7C),Vaginol (7T),Smyrindiol (8C),Xanthoarnol (8T),And Avicenol A (9T). Acid-Catalyzed Fragmentation Of Vaginidiol Or Vaginol Provides Angelicin,While That Of Smyrindiol Or Xanthoarnol Affords Psoralen. In Both Cases,The Trans Isomers Fragment Only Twice As Fast As The Cis Isomers,Possibly Through The Intermediacy Of A Common Benzylic Cation. This May Have Implications For The Biosynthesis Of Angelicin And Psoralen.
DOI:10.1021/jo047974K

海关参考信息

专利信息


专利号:US-5139940-A
优先权日:1989-10-26
标题 :Activation compounds and methods of synthesis of activation compounds
发明人:ISAACS STEPHEN T; CIMINO GEORGE D; METCHETTE KENNETH C; TESSMAN JOHN W
权利人:ISAACS STEPHEN T; CIMINO GOERGE D; METCHETTE KENNETH C; TESSMAN JOHN W
摘要:The invention is directed to isopsoralen compound compositions that contain a variety of substitutions which yet permit their binding to nucleic acid polymers. Reaction conditions that activate these bound isopsoralens results in covalent crosslinking to the nucleic acid polymers. The resultant complex is inhibited from being a template for the template-directed enzymatic synthesis of a complementary nucleic acid polymer. Beside the isopsoralens compositions, the invention includes their synthesis, the nucleic acid complex production and detection, and the above inhibitory method of use of the isopsoralens.

专利号:WO-2024153642-A1
优先权日:2023-01-16
标题 :Scarless template-free enzymatic synthesis of polynucleotides
发明人:HORGAN ADRIAN; VERARDO DAMIANO; ADELIZZI BEATRICE; RODRIGUEZ-PINZON DANIEL; THOMEE EMMA
权利人:DNA SCRIPT
摘要:Methods are provided for template-free enzymatic synthesis of polynucleotides on a solid support using double cleavage to produce scarless polynucleotides. In particular, methods are disclosed that use an initiator that comprises a cleavable group, which can be cleaved by a small molecule chemical agent, adjusting pH, heat, or photocleaved by illumination with light to release polynucleotides from a solid support after enzymatic synthesis is completed, and an enzymatic cleavage site, which can be cleaved by a cleavage enzyme to remove polynucleotide scars.

专利号:US-12146136-B2
优先权日:2020-03-26
标题:Synthesis of modified oligonucleotides with increased stability
发明人:KHVOROVA ANASTASIA; ROUX LOÃ?C MAURICE RENÉ JEAN; YAMADA KEN
权利人:UNIV MASSACHUSETTS
摘要:This disclosure relates to the synthesis of novel modified oligonucleotides. The synthesis of novel phosphoramidites are also provided.

专利号:US-7183095-B2
优先权日:2001-03-09
标题:Cell culture system for synthesis of infectious hepatitis C virus
发明人:DASGUPTA ASIM; KOKA PRASAD S
权利人:UNIV CALIFORNIA
摘要:The invention rates to a hepatitis C virus (HCV) cDNA-based culture system capable of synthesis of infectious HCV in cell culture and cell-to-cell spread of the virus. The invention also relates to a method of measuring the level of HCV infection in a hepatocyte cell. A method for identifying a modulator of HCV activity is also presented, and a method for modulating HCV activity. The invention provides a reliable system for both genetic analysis of the viral genome and for the development of novel antiviral strategies.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-9440940-B2
优先权日:2014-03-18
标 题:Methods for synthesis of psoralen derivatives
发明人:REFOUVELET BERNARD
权利人:MACOPHARMA S A S
摘要:Methods for the synthesis of psoralen derivatives are provided. In one embodiment, the method may include acetylating a compound of formula (II) to form a compound of formula (III), subjecting the compound of formula (III) to a Fries rearrangement to form a compound of formula (IV), and subjecting the compound of formula (IV) to cyclization, reduction and aromatization, to form a compound having the following formula (I):
北京海步国际医药科技发展有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hopelife.cn
电话: 86-10-67886402👤
📞北京海步国际医药科技发展有限公司 ⚠️参考联系方式

销售电话:86-10-67886402
邮箱:apis@hopelife.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
西安昌岳植物化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.shxchangyue.com
电话: 86-029-62886900 14729776523👤
📞西安昌岳植物化工有限公司 ⚠️参考联系方式

销售电话:86-029-62886900 14729776523
邮箱:286018839@qq.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:西安市高新区科技路70号梧桐朗座21801
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
成都健腾生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.aktinchem.com
电话: 86-28-85159085👤
📞成都健腾生物技术有限公司 ⚠️参考联系方式

销售电话:86-28-85159085
邮箱:info@aktinchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海友思生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.useash.com/cn/index.htm
电话: 021-56641571👤
📞上海友思生物技术有限公司 ⚠️参考联系方式

销售电话:021-56641571
邮箱:info@useash.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
苏州润新生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.neupharma.com
电话: 0512-62956991👤
📞苏州润新生物科技有限公司 ⚠️参考联系方式

销售电话:0512-62956991
邮箱:sales@neupharma.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s12012-010-9065-z
摘要:Torres SM, Divi RL, Walker DM, McCash CL, Carter MM, Campen MJ, Einem TL, Chu Y, Seilkop SK, Kang H, Poirier MC, Walker VE. In Utero Exposure of Female CD-1 Mice to AZT and/or 3TC: II. Persistence of Functional Alterations in Cardiac Tissue. Cardiovascular Toxicology. 2010 Feb 13;10(2):87–99. doi: 10.1007/s12012-010-9065-z.
参考文献:10.1007/978-1-61779-188-8_1
摘要:Goodchild J. Therapeutic oligonucleotides. Methods Mol Biol. 2011;764():1–15. doi: 10.1007/978-1-61779-188-8_1.
参考文献:10.2147/ccid.s17917
摘要:Uhlenhake EE, Mehregan DA. Ustekinumab: differential use in psoriasis. Clin Cosmet Investig Dermatol. 2011;4():93–9.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知